The association of plasma copeptin with both cardiovascular disease [9,10] and T2D [6,7] prompted us to stratify the study cohort according to categories of glucose tolerance in order to examine a possible contribution of elevated copeptin to the high cardiovascular risk in diabetes. Here, AVP is linked to type 2 diabetes mellitus.